Insider selling
Traded Jun 3 · filed 1 day laterNot reported under a pre-arranged trading plan
An Insulet director sold $60K of Insulet shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 13, 2026
44 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 13, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Increased
Compared with the manager's Q4 2025 13F
659,057
692,974
+5.1%
Share count drives classification; reported value also moves with price
0.23%
Within the filing's reported positions, not the manager's total assets
44
For Q1 2026
Insider selling
Traded Jun 3 · filed 1 day laterNot reported under a pre-arranged trading plan
An Insulet director sold $60K of Insulet shares. The filing does not indicate a pre-arranged trading plan.
Insider buying
Traded Jun 3 · filed 1 day later
An Insulet director paid $400K out of pocket for Insulet shares. 1 other person at Insulet bought some too, in the same month. It was the first purchase in 6 months.
Insider buying
Their first buy on recordTraded Jun 3 · filed the same day
An Insulet director paid $497K out of pocket for Insulet shares. 1 other person at Insulet bought some too, in the same month. Shares held went up 50% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.